CN1255132C - Nasosinusitis treating medicine and its preparing process - Google Patents
Nasosinusitis treating medicine and its preparing process Download PDFInfo
- Publication number
- CN1255132C CN1255132C CN 200310110176 CN200310110176A CN1255132C CN 1255132 C CN1255132 C CN 1255132C CN 200310110176 CN200310110176 CN 200310110176 CN 200310110176 A CN200310110176 A CN 200310110176A CN 1255132 C CN1255132 C CN 1255132C
- Authority
- CN
- China
- Prior art keywords
- drugs
- present
- crude drugs
- drug
- gmel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- 241000688694 Cheilanthes argentea Species 0.000 claims description 23
- 241000628997 Flos Species 0.000 claims description 22
- 239000002994 raw material Substances 0.000 claims description 17
- 201000009890 sinusitis Diseases 0.000 claims description 12
- 238000010298 pulverizing process Methods 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 229940079593 drug Drugs 0.000 abstract description 23
- 206010061218 Inflammation Diseases 0.000 abstract description 9
- 230000004054 inflammatory process Effects 0.000 abstract description 6
- 210000004072 lung Anatomy 0.000 abstract description 5
- 241000183291 Aleuritopteris Species 0.000 abstract 5
- 241000723353 Chrysanthemum Species 0.000 abstract 3
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 3
- 235000013399 edible fruits Nutrition 0.000 abstract 3
- 230000003115 biocidal effect Effects 0.000 abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 7
- 206010019233 Headaches Diseases 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 206010028748 Nasal obstruction Diseases 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 201000006916 frontal sinusitis Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000003773 Meningism Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000013088 frontal headache Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
The present invention discloses a drug for treating nasosinusitis, which is characterized in that the drug is prepared from crude drugs of the following proportion: 1 part by weight of sivery aleuritopteris herb, 0 to 0.2 part by weight of dark plum fruit and 0 to 0.2 part by weight of chrysanthemum. The present invention has the advantages that the drug is prepared by selecting three crude drugs of the sivery aleuritopteris herb, the dark plum fruit and the chrysanthemum through scientific development for many years according to the compatible principles of sovereign drugs, minister drugs, adjuvant drugs and envoy drugs on the basis of Chinese medicine theories; the sivery aleuritopteris herb of the crude drugs is selected as the sovereign drug for the pharmacological action that the sivery aleuritopteris herb is cold in nature and can enter three meridians and vessels of the liver, kidney and lung, and the efficacy of heat-clearing, detoxication, lung release, orifice release, antibiosis and inflammation relief; the dark plum fruit and the chrysanthemum of the crude drugs also have the functions of antibiosis, inflammation relief, heat-clearing and detoxication, and can jointly assist the sivery aleuritopteris herb of the crude drugs to relieve inflammation and alleviate pain. Therefore, the drug of the present invention has remarkable advantages of quick action, high treatment rate, and radical treatment without relapses; simultaneously, the crude drugs of the present invention are cheap and accessible, and the preparation process is simple due to less crude drugs.
Description
Technical field:
The present invention relates to a kind of medicine for the treatment of sinusitis and preparation method thereof, belong to the field of Chinese medicines.
Background technology:
Sinusitis is the department of otorhinolaryngology common clinical, and its cause of disease is mainly frontal sinusitis and headache of causing, dizziness, nasal obstruction etc.Adopt quiet penicillin or go up the sinus frontalis paracentesis the treatment of sinusitis more at present.The existing not enough first of above-mentioned Therapeutic Method is brought sensual misery to the patient, and it two is to effect a radical cure, the relapse rate height; And still there is the deficiency that can not effect a radical cure in the oral anti-inflammatory drug that is used for the treatment of sinusitis at present, and the property of medicine is slow, and treatment cycle is long.
Summary of the invention:
The present invention's purpose is to provide a kind of medicine for the treatment of sinusitis, and it not only can effect a radical cure sinusitis and be difficult for recurrence, and instant effect, and cost is low.
Another purpose of the present invention is to provide manufacturing method for above mentioned medicine.
For achieving the above object, the present invention can be achieved through the following technical solutions:
Medicine of the present invention is to be made according to the following weight parts proportioning by raw material Aleuritopteris argentea (Gmel.) Fee, Fructus Mume, Flos Chrysanthemi:
Aleuritopteris argentea (Gmel.) Fee: 1 part; Fructus Mume: 0.001-0.2 part; Flos Chrysanthemi: 0.001-0.2 part.
Weight portion proportioning between raw material Aleuritopteris argentea (Gmel.) Fee in the medicine of the present invention, Fructus Mume, the Flos Chrysanthemi may be selected to be 1: 0.001: 0.001.
Weight portion proportioning between raw material Aleuritopteris argentea (Gmel.) Fee in the medicine of the present invention, Fructus Mume, the Flos Chrysanthemi also may be selected to be 1: 0.1: 0.1.
Weight portion proportioning between raw material Aleuritopteris argentea (Gmel.) Fee in the medicine of the present invention, Fructus Mume, the Flos Chrysanthemi also may be selected to be 1: 0.2: 0.2.
The preparation method of medicine of the present invention is for making capsule with Aleuritopteris argentea (Gmel.) Fee, Fructus Mume, Flos Chrysanthemi drying after pulverizing according to described proportioning.
The preparation method of medicine of the present invention also can be according to described proportioning Aleuritopteris argentea (Gmel.) Fee, Fructus Mume, Flos Chrysanthemi drying is made tablet after pulverizing.
Advantage of the present invention is based on the theory of Chinese medical science of China, according to the combination principle of monarch, selects Aleuritopteris argentea (Gmel.) Fee, Fructus Mume, Flos Chrysanthemi three flavor raw materials, develops through science for many years.Selecting the raw material Aleuritopteris argentea (Gmel.) Fee is that it has lightly seasoned, lung qi dispersing cough-relieving, regulating menstruation, functions dispelling wind and clearing away cold, removing dampness as monarch drug, goes into that the pharmacology of lung meridian and heat-clearing and toxic substances removing, lung qi dispersing are sensible, the effect of anti-inflammation; And raw material Fructus Mume, Flos Chrysanthemi also have the effect of anti-inflammation, heat-clearing and toxic substances removing and common assistant helps raw material Aleuritopteris argentea (Gmel.) Fee anti-inflammatory analgetic, thereby make medicine of the present invention have the remarkable result that instant effect, cure rate height, radical cure do not recur.Raw material of the present invention is cheap and easy to get simultaneously, and the raw material of selecting for use is few thereby preparation technology is simple.
For further setting forth the beneficial effect that the present invention had, be illustrated below by clinical case: case 1:
Certain woman: 13 years old.
The main suit: headache, dizziness, stream 2 weeks of yellow thick nasal discharge, 36.6 ℃ of body temperature, last sinus frontalis has tenderness; Film making checks that last sinus frontalis inflammation is failed to respond to any medical treatment through quiet penicillin.
Treatment: oral medicine of the present invention headache, dizziness in 2 days alleviate, and oral described medicine is after 7 days, and above-mentioned symptom disappears, no insomnia, twinge and meningeal irritation symptom.Pay a return visit after 2 months, 2 sinusitis of catching a cold do not have recurrence.
Case 2:
Certain man: 10 years old.
The main suit: headache is surplus February, and increase the weight of evening, does not have nasal obstruction, and 36.5 ℃ of body temperature have 4 years sinusitis histories, use general Drug therapy invalid.
Check: going up sinus frontalis has tenderness, and film making inspection is gone up the sinus frontalis inflammation.
Treatment: oral medicine of the present invention headache in 7 days transference cure, do not have insomnia, twinge.Pay a return visit after half a year, do not have recurrence.
Certain woman: 36 years old.
The main suit: headache, feeling of fullness in the head, a muddled March are surplus, 36.7 ℃ of body temperature, and last sinus frontalis has the tenderness sense, does not have nasal obstruction, has 13 years and goes up the frontal sinusitis history, and general anti-inflammation drugs is invalid.
Check: sinus frontalis inflammation in the film making.
Treatment: 7 days above-mentioned sxs of oral medicine of the present invention, behind the first quarter moon that continues to take medicine, above-mentioned symptom disappears, and pays a return visit after half a year, does not have recurrence.
The specific embodiment:
Embodiment 1:
Medicine of the present invention is to be made according to the following weight parts proportioning by raw material Aleuritopteris argentea (Gmel.) Fee, Fructus Mume, Flos Chrysanthemi:
Get 1 part of Aleuritopteris argentea (Gmel.) Fee, 0.1 part of Fructus Mume, 0.1 part of Flos Chrysanthemi; Get final product making capsule after this three flavors raw material pulverizing.
Embodiment 2:
Medicine of the present invention is to be made according to the following weight parts proportioning by raw material Aleuritopteris argentea (Gmel.) Fee, Fructus Mume, Flos Chrysanthemi:
Get 1 part of Aleuritopteris argentea (Gmel.) Fee, 0.001 part of Fructus Mume, Flos Chrysanthemi 0.001; Get final product making tablet after this three flavors raw material pulverizing.
Embodiment 3:
Medicine of the present invention is to be made according to the following weight parts proportioning by raw material Aleuritopteris argentea (Gmel.) Fee, Fructus Mume, Flos Chrysanthemi:
Get 1 part of Aleuritopteris argentea (Gmel.) Fee, 0.2 part of Fructus Mume, Flos Chrysanthemi 0.2; Get final product making capsule after this three flavors raw material pulverizing.
Claims (6)
1, a kind of medicine for the treatment of sinusitis is characterized in that: it is to be made according to the following weight parts proportioning by raw material Aleuritopteris argentea (Gmel.) Fee, Fructus Mume, Flos Chrysanthemi:
Aleuritopteris argentea (Gmel.) Fee: 1 part; Fructus Mume: 0.001-0.2 part; Flos Chrysanthemi: 0.001-0.2 part.
2, medicine according to claim 1 is characterized in that: the weight portion proportioning between described Aleuritopteris argentea (Gmel.) Fee, Fructus Mume, the Flos Chrysanthemi is 1: 0.001: 0.001.
3, medicine according to claim 1 is characterized in that: the weight portion proportioning between described Aleuritopteris argentea (Gmel.) Fee, Fructus Mume, the Flos Chrysanthemi is 1: 0.1: 0.1.
4, medicine according to claim 1 is characterized in that: the weight portion proportioning between described Aleuritopteris argentea (Gmel.) Fee, Fructus Mume, the Flos Chrysanthemi is 1: 0.2: 0.2.
5, according to the preparation method of the medicine of the described treatment sinusitis of claim 1: it is characterized in that: will described Aleuritopteris argentea (Gmel.) Fee, Fructus Mume, Flos Chrysanthemi drying make capsule after pulverizing.
6, according to the preparation method of the medicine of the described treatment sinusitis of claim 1: it is characterized in that: will described Aleuritopteris argentea (Gmel.) Fee, Fructus Mume, Flos Chrysanthemi drying make tablet after pulverizing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200310110176 CN1255132C (en) | 2003-11-21 | 2003-11-21 | Nasosinusitis treating medicine and its preparing process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200310110176 CN1255132C (en) | 2003-11-21 | 2003-11-21 | Nasosinusitis treating medicine and its preparing process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1544024A CN1544024A (en) | 2004-11-10 |
| CN1255132C true CN1255132C (en) | 2006-05-10 |
Family
ID=34335541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200310110176 Expired - Fee Related CN1255132C (en) | 2003-11-21 | 2003-11-21 | Nasosinusitis treating medicine and its preparing process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1255132C (en) |
-
2003
- 2003-11-21 CN CN 200310110176 patent/CN1255132C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1544024A (en) | 2004-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104547826B (en) | Galangal rhizome extract treats the medical usage of dysmenorrhoea | |
| CN101214304A (en) | Chinese medicine prescription for treating chronic cholecystitis | |
| CN1130219C (en) | Litholysizing bear gall powder | |
| CN1191847C (en) | Medicated pillow and its making process | |
| CN1255132C (en) | Nasosinusitis treating medicine and its preparing process | |
| CN1254254C (en) | Chinese patent drug for treating nasosinusitis | |
| CN1404854A (en) | Medicine for treating nosal inflammation | |
| CN1660256A (en) | A medicine for treating cough caused by upper respiratory tract inflammation | |
| CN1301743C (en) | Chinese medicinal formula for treating chronic bronchitis | |
| CN1059801C (en) | Medicament for treating rheum | |
| CN1468629A (en) | Traditional Chinese medicine composition for treating wind-heat type common cold and preparation method thereof | |
| CN1265816C (en) | Lotion for curing hemorrhoid | |
| CN1111051C (en) | Medicine for treating cough and asthma | |
| CN104740217A (en) | Traditional Chinese medicinal composition for treating rhinitis and preparation method thereof | |
| CN1052908C (en) | "Chanhouning" and its preparation method | |
| CN100342864C (en) | Medicine for treating chronic hemorrhoids | |
| CN1264544C (en) | Nasal suppository for treating thinitis | |
| CN101612321A (en) | Traditional Chinese medicine for treating facial paralysis and prosopodynia | |
| CN107095917A (en) | A kind of Chinese medicine composition for preventing and treating abscess of throat, canker sore and its preparation method and application | |
| CN1116071C (en) | Medicine for treating asthma | |
| CN1063081C (en) | Chinese medicine composite for curing chronic upper jaw sinuitis | |
| CN1785403A (en) | Jindan gallbladder stone dissolving capsule | |
| CN1903327A (en) | Traditional Chinese medicine for treating epilepsy | |
| CN1280839A (en) | Chinese-medicinal nose drops for treating acute or chronic rhinitis and its preparing process | |
| CN1335140A (en) | Medicine bolus for dredging meridian passage, nourishing blood and removing toxic material |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |